Protide Pharmaceuticals, Inc. is dedicated to advancing research and development in various fields, including regenerative medicine, cancer biology, and cell bioenergy. The company offers innovative solutions that enhance the physiological conditions of cells through their serum replacements, which are designed to create a biologically consistent and functional environment. These serum replacements are formulated as 50X concentrates, significantly reducing costs and improving storage and supply chain efficiency. By eliminating components such as phenol red, growth factors, and steroid hormones, Protide's technology allows for more accurate studies of cellular functions and the purification of cell-secreted proteins without contamination from serum components.

In addition to serum replacements, Protide Pharmaceuticals provides specialized solutions for islet cell transplantation, including cold storage and purification stock solutions. Their products are manufactured under current Good Manufacturing Practices (cGMP) to ensure quality and reliability. The focus on controlling the in vitro environment enables researchers to generate consistent biological data, facilitating insights into cellular processes and the commercial production of therapeutic proteins and vaccines. Overall, Protide's commitment to innovation and quality positions it as a significant contributor to advancements in cell technology and related fields.

United States

Protide Pharmaceuticals, Inc. is a fully integrated organization devoted to discovery, development and the advancement of technologies and processes in clinical cell therapy, regenerative medicine, transplantation and cell engineering.

With over 35 years of innovative products and services, and hundreds of clinical trials using our technology, we positively impact science through knowledge. Inspired by the scientists, patients, and physicians we support, Protide continues as an entrepreneurial, science driven organization.

Protide Pharmaceuticals

Company Details